A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This trial is to evaluate the efficacy and safety of CWP-0403 at 100 mg or 200 mg twice daily
compared with placebo in type 2 diabetic patients with inadequate glycemic control by diet
therapy or combination of diet and exercise therapy.